重症动脉瘤性蛛网膜下腔出血管理专家共识(2023)

·126·中国脑血管病杂志2023年2月18日第20卷第2期Chin J Cerebrovase Dis,Fh.18.2023Vdl.20.Na.2指南与共识·重症动脉瘤性蛛网膜下腔出血管理专家共识(2023)中国医师协会神经外科医师分会神经重症专家委员会中华医学会神经外科学分会脑血管病学组中国医师协会神经介入专业委员会北京医学会神经外料学分会神经外科危重症学组摘要：动脉瘤性蛛网膜下腔出血是神经外科的常见危重病，致死、致残率高，其临床诊断、治疗涉及脑血管外科、脑血管介入及神经重症多个学科。对于重症动脉瘤性蛛网膜下腔出血患者，在对动脉瘤进行治疗前后，因原发脑组织损害、继发脑组织缺血、颅内压增高以及系统性并发症等，需在围手术期进行神经重症监护治疗·中国医师协会神经外科医师分会神经重症专家委员会、中华医学会神经外科学分会脑血管病学组、中国医师协会神经介人专业委员会，北京医学会神经外科学分会神经外科危重症学组组织专家回顾总结近8年来国内外高质量临床研究结果，结合专家临床实践，对《重症动脉瘤性蛛网膜下腔出血管理专家共识015)进行了更新与修订，重点聚焦于该疾病造成的脑损害及一系列并发症的神经重症管理，供危重症医学、神经重症、神经内外科、急诊医师参考，以提高我国重症动脉瘤性蛛网膜下腔出血围手术期的规范化诊疗水平。关键词：蛛网膜下腔出血；顿内动脉瘤：重症管理；专家共识dad:10.3969/j.issn.16725921.2023.02.009Expert consensus on the management of severe aneurysmal subarachnoid hemorrhage 2023Neurointensive Care Expert Committee of Chinese Neurosurgeons Association;Cerebrovascular Group,Chinese Neurosurgical Society;Chinese Federation of Interventional Clinical Neurosciences(CFITN):Neurosurgery Critical Care Group,Beijing Neurosurgical SocietyCorresponding authors:Wang Ning,Department of Neurosurgery,Xuanwou Hospital,Capital MedicalUniversity,Beijing 10053,China,Email:ninging_ud@163.com;Kang Dezhi,Department of Neurosurgery,the First Affiliated Hospital of Fujian Medical University,Fuho 3005,China,Email:kd9988@sina.com:Hu Jin,Depanment of Neurosurgery.Huashan Hospital Affiliated to Fudan Unirersity.Shanghai 200040.China,Email:hujin_dana@126.com:Zhang Hongqi,Department of Neurosurgery,Xuaneu Hospital,Capital Medical University,Beijing 100053,China,Email:xwzhanghg@163.comAbstract:Aneurysmal subarachnoid hemorrhage is a common critical disease in neurosurgery with ahigh mortality and disability.Its clinical diagnosis and treatment involve multidisciplinary medical services,including cerebrovascular surgery,cerebrovascular intervention and neurocritical care.Patients sufferedfrom severe aneurysmal subarachnoid hemorrhage SaSAH),with primary brain injury occurs afteraneurysm bleeding and secondary cerebral ischemia,intracranial pressure increase and systemic complications,need perioperative neurological intensive care treatment.Neurointensive Care Expert Committee ofChinese Neurosurgeons Association,Cerebrovascular Group,Chinese Neurosurgical Society,Chinese Federation of Interventional Clinical Neurosciences,Neurosurgery Critical Care Group,BeijingNeursurgical Society,organized experts to review and summarize the results of high-quality clinical studies基金项日：国家重，点研发计划重大慢性非传染性疾病防控研究重点专项资助项目(2016YFC1300800)通信作者：王宁，100053北京，首都医科大学宜武医院神经外科，Email:ningjing-wd@163.com,康德智，350005福州，福建医科大学附属第一医院神经外科.Email:kd99988@sim.om:胡锦，200040上海，复旦大学附属华山医院神经外科，Email:hjin_dama@126.com;张湾祺，100053北京，首都医科大学宣武医院神经外科，Email:xwzhanghq@163.com(C)1994-2023 China Academic Journal Electronic Publishing House.All rights reserved.http://www.cnki.net